| MeSH term | MeSH ID | Detail |
|---|---|---|
| Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative | D054438 | 1 associated lipids |
| Hashimoto Disease | D050031 | 1 associated lipids |
| Legg-Calve-Perthes Disease | D007873 | 1 associated lipids |
| Fluorosis, Dental | D009050 | 1 associated lipids |
| Bone Demineralization, Pathologic | D018488 | 1 associated lipids |
| POEMS Syndrome | D016878 | 1 associated lipids |
| Fibroma, Ossifying | D018214 | 1 associated lipids |
| Osteolysis, Essential | D010015 | 1 associated lipids |
| Hemangioma, Capillary | D018324 | 1 associated lipids |
| Dentin Dysplasia | D003805 | 1 associated lipids |
7-octadecynoic acid
7-octadecynoic acid is a lipid of Fatty Acyls (FA) class.
Cross Reference
There are no associated biomedical information in the current reference collection.
Current reference collection contains 19785 references associated with 7-octadecynoic acid in LipidPedia. Due to lack of full text of references or no associated biomedical terms are recognized in our current text-mining method, we cannot extract any biomedical terms related to diseases, pathways, locations, functions, genes, lipids, and animal models from the associated reference collection.
Users can download the reference list at the bottom of this page and read the reference manually to find out biomedical information.
Here are additional resources we collected from PubChem and MeSH for 7-octadecynoic acid
Possible diseases from mapped MeSH terms on references
We collected disease MeSH terms mapped to the references associated with 7-octadecynoic acid
All references with 7-octadecynoic acid
Download all related citations| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| Miyamoto A et al. | Establishment and characterization of an immortal macrophage-like cell line inducible to differentiate to osteoclasts. | 1998 | Biochem. Biophys. Res. Commun. | pmid:9464281 |
| Yamaguchi K et al. | Characterization of structural domains of human osteoclastogenesis inhibitory factor. | 1998 | J. Biol. Chem. | pmid:9478964 |
| Yasuda H et al. | Identity of osteoclastogenesis inhibitory factor (OCIF) and osteoprotegerin (OPG): a mechanism by which OPG/OCIF inhibits osteoclastogenesis in vitro. | 1998 | Endocrinology | pmid:9492069 |
| Yasuda H et al. | Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL. | 1998 | Proc. Natl. Acad. Sci. U.S.A. | pmid:9520411 |
| Lacey DL et al. | Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation. | 1998 | Cell | pmid:9568710 |
| Tomoyasu A et al. | Characterization of monomeric and homodimeric forms of osteoclastogenesis inhibitory factor. | 1998 | Biochem. Biophys. Res. Commun. | pmid:9571159 |
| Bucay N et al. | osteoprotegerin-deficient mice develop early onset osteoporosis and arterial calcification. | 1998 | Genes Dev. | pmid:9573043 |
| Matsuzaki K et al. | Osteoclast differentiation factor (ODF) induces osteoclast-like cell formation in human peripheral blood mononuclear cell cultures. | 1998 | Biochem. Biophys. Res. Commun. | pmid:9600092 |
| Emery JG et al. | Osteoprotegerin is a receptor for the cytotoxic ligand TRAIL. | 1998 | J. Biol. Chem. | pmid:9603945 |
| Tsukii K et al. | Osteoclast differentiation factor mediates an essential signal for bone resorption induced by 1 alpha,25-dihydroxyvitamin D3, prostaglandin E2, or parathyroid hormone in the microenvironment of bone. | 1998 | Biochem. Biophys. Res. Commun. | pmid:9610359 |